Sukumar Nagendran
President and Head of R&D at Taysha Gene Therapies Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Taysha Gene Therapies Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Solid Biosciences Inc. June 12, 202591.8%
-
Taysha Gene Therapies Inc. June 2, 202589.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −200,000 | $6.24 | $1,248,000 |
| Apr 10, 2026 | Taysha Gene Therapies Inc. | Option exercise | +19,021 | $1.71 | $32,526 |
| Apr 10, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −200,000 | $4.46 | $892,000 |
| Jan 26, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −26,918 | $4.61 | $124,092 |
| Jan 23, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −89,132 | $4.75 | $423,377 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Option exercise | +111,324 | $0.70 | $77,927 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Option exercise | +88,676 | $1.71 | $151,636 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −200,000 | $4.71 | $942,000 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Grant or award | +427,000 | — | — |
| Dec 1, 2025 | Taysha Gene Therapies Inc. | Option exercise | +260,047 | $1.71 | $444,680 |
| Dec 1, 2025 | Taysha Gene Therapies Inc. | Open-market sale | −260,047 | $4.51 | $1,172,812 |
| Nov 28, 2025 | Taysha Gene Therapies Inc. | Option exercise | +70,172 | $0.70 | $49,120 |
| Nov 28, 2025 | Taysha Gene Therapies Inc. | Option exercise | +39,953 | $1.71 | $68,320 |
| Nov 28, 2025 | Taysha Gene Therapies Inc. | Open-market sale | −110,125 | $4.75 | $523,094 |
| Sep 10, 2025 | Taysha Gene Therapies Inc. | Option exercise | +41,150 | $0.70 | $28,805 |
Questions about Sukumar Nagendran
What boards is Sukumar Nagendran on?
Sukumar Nagendran sits on the boards of Solid Biosciences Inc. and Taysha Gene Therapies Inc.
How long has Sukumar Nagendran served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.